Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1197)
  3. Review (75)
  4. Research Letter (48)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2969)
  2. Department of Medicine (2969)
  3. Hematologic Malignancies, Division of (2846)
  4. Survivorship Research (1387)
  5. GSK Faculty (931)
  6. CTCR Scholars (872)

More Groups

People
  1. Sergio Giralt (1067)
  2. Miguel-Angel Perales (942)
  3. Sean Devlin (469)
  4. Ann Jakubowski (458)
  5. Gunjan Shah (446)
  6. Heather Landau (435)

More People

Years
  1. 2025 (66)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (94)

More Publications

Publishers
  1. American Society of Hematology (988)
  2. Elsevier Inc. (766)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2969)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
    Research Letter

    Hultcrantz, M.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; Lahoud, O. B.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Donor types and outcomes of transplantation in myelofibrosis: A CIBMTR study
    Journal Article

    Jain, T.; Estrada-Merly, N.; Salas, M. Q.; Kim, S.; DeVos, J.; Chen, M.; Fang, X.; Kumar, R.; Andrade-Campos, M.; Elmariah, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation
    Meeting Abstract

    Al Malki, M. M.; Bo-Subait, S.; Logan, B.; Olson, J.; Leckrone, E.; Wu, J.; Stefanski, H. E.; Auletta, J. J.; Spellman, S. R.; Malmberg, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase III, randomized study of daratumumab, cyclophosphamide, bortezomib and dexamethasone (DARA-VCD) induction followed by autologous stem cell transplant or DARA-VCD consolidation and daratumumab maintenance in patients with newly diagnosed AL amyloidosis
    Meeting Abstract

    Hagen, P.; Sidana, S.; Parker, T. L.; Walker, B. K.; Hoering, A.; Sanchorawala, V.; Zonder, J. A.; Kourelis, T.; D'Souza, A.; Landau, H. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Safety outcomes in patients with acute myeloid leukemia receiving gemtuzumab ozogamicin and proceeding to allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Kebriaei, P.; Ho, V.; Perales, M. A.; Bejanyan, N.; Kaur, M.; Zhang, M. J.; D'Amico, P. G.; Purcell, S.; Dorman, S.; Vandendries, E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Multicenter, randomized phase II study of epcoritamab for patients with large B-cell lymphomas achieving a partial response after CD19-directed CAR T-cell therapy (CAR-T)
    Meeting Abstract

    Bock, A. M.; Raj, S.; Giri, S.; Leslie, L. A.; Patel, D. A.; Iqbal, M.; Grover, N. S.; Hu, B.; Perales, M. A.; Nowakowski, G. S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Safety outcomes in adult patients with AML who achieved their first complete remission with GO prior to HSCT
    Meeting Abstract

    Bejanyan, N.; Ho, V.; Perales, M. A.; Kebriaei, P.; Kaur, M.; Zhang, M. J.; D'Amico, P. G.; Purcell, S.; Dorman, S.; Vandendries, E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Impact of late immune effector cell associated hematotoxicity (ICAHT) and prolonged neutropenia after CAR-T therapy on infection and survival outcomes
    Meeting Abstract

    Zenner, M.; Lessans, S.; Rejeski, K.; Perales, M. A.; Maziarz, R. T.; Chen, A. I.; Porter, D. L.; Schuster, S. J.; McGuirk, J.; Bishop, M. R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Biomarkers in a phase 1b study of investigational microbiome therapeutic SER-155 in adults undergoing allogeneic hematopoietic cell transplantation (allo-HCT)
    Meeting Abstract

    Ponce, D. M.; Pandian, S.; van den Brink, M. R. M.; Kosuri, S.; Khera, N.; DeFilipp, Z. M.; Tejura, B.; Lichter, D. I.; Chafee, M.; Bardhan, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Tan, C. R. C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Shah, G. L.; Scordo, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save